(Q47976225)
Statements
1 reference
Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer. (English)
1 reference
S Wojtowicz-Praga
1 reference
J Torri
1 reference
M Johnson
1 reference
V Steen
1 reference
J Marshall
1 reference
E Ness
1 reference
R Dickson
1 reference
M Sale
1 reference
H S Rasmussen
1 reference
T A Chiodo
1 reference
M J Hawkins
1 reference
1 June 1998
1 reference
1 reference
16
1 reference
2150-2156
1 reference
6
1 reference
Identifiers
1 reference
1 reference